John A Hangasky

6PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologiesMedical biochemistry - proteins and peptides (incl. medical proteomics)Innate immunityFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
PEG-RLI: A Long-Acting IL-15 Agonist That Produces Massive Levels of CD8+ and CD44hiCD8+ Cells for Cancer Immunotherapy.

|Feb 03, 2025
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides.

Eric L Schneider, John A Hangasky, Gary W Ashley

|Nov 12, 2024
The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing.

Eric L Schneider, John A Hangasky, Rocío Del Valle Fernández

|Feb 01, 2022
A very long-acting IL-15: implications for the immunotherapy of cancer.

John A Hangasky, Wei Chen, Sigrid P Dubois

|Jun 12, 2020
An iron (II) dependent oxygenase performs the last missing step of plant lysine catabolism.

Mitchell G Thompson, Jacquelyn M Blake-Hedges, Jose Henrique Pereira

|Aug 28, 2019
Regional and correlative sweat analysis using high-throughput microfluidic sensing patches toward decoding sweat.

Hnin Yin Yin Nyein, Mallika Bariya, Liisa Kivimäki

Pageof 1

Frequent Collaborators

2 joint publications

Daniel V Santi

2 joint publications

Rocío Del Valle Fernández

2 joint publications

Eric L Schneider

1 joint publications

Guillermo Hails